Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia (Q38272641)

1 September 2017

1 reference

title

Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia (English)

1 reference

1 September 2017

0 references

Anita Pratt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

Anthony J Borg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

Bill Kalionis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

Rosemary Keogh

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

publication date

30 November 2014

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

115-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433512 AND SRC:MED&resulttype=core&format=json

Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Implantation and the placenta: key pieces of the development puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Endoglin in angiogenesis and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

The global impact of pre-eclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Role of vascular endothelial growth factor in ovarian physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Epidemiology and causes of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Growth and function of the normal human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Vascular endothelial growth factor and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Preeclampsia and angiogenic imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Molecular mechanisms of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Second-trimester uterine artery Doppler screening in unselected populations: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Expression pattern of collagen XVIII and its cleavage product, the angiogenesis inhibitor endostatin, at the fetal-maternal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Endostatin suppresses IGF-II-mediated signaling and invasion of human extravillous trophoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

First-trimester prediction of hypertensive disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Initiation of aspirin in early gestation for the prevention of pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Pathogenesis and genetics of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Pre-eclampsia and thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Soluble fms-like tyrosine kinase-1 and the progression of carotid intima-media thickness – 24-month follow-up study –.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Diagnosis and management of gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 0 to 24 6 weeks' gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Vascular function in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Epidemiology of Pregnancy-induced Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10456-014-9452-3